Alexsandra Espejo

Alexsandra Espejo

Auto-generated profile, based on publicly available information

Alexsandra Espejo

Immunotherapy Platform and James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2007 in Nature
Verified
Journal Article
Closed access
PDF file
JHJing Huang
Jing Huang
RSRoopsha Sengupta
Roopsha Sengupta
AEAlexsandra B. Espejo
Alexsandra B. Espejo
MLMin Gyu Lee
Min Gyu Lee
JDJean A. Dorsey
Jean A. Dorsey
SBShelley L. Berger
Shelley L. Berger

13 January 2006 in EMBO Reports
Verified
Journal Article
Open access
PDF file
JKJeesun Kim
Jeesun Kim
JDJeremy Daniel
Jeremy Daniel
AEAlexsandra Espejo
Alexsandra Espejo
ALAimee Lake
Aimee Lake
MKMurli Krishna
Murli Krishna
MBMark T Bedford
Mark T Bedford
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 August 2008 in Genes & Development
Verified
Journal Article
Closed access
PDF file
GSGunnar Schotta
Gunnar Schotta
RSRoopsha Sengupta
Roopsha Sengupta
SKStefan Kubicek
Stefan Kubicek
SMStephen Malin
Stephen Malin
MKMonika Kauer
Monika Kauer
TJThomas Jenuwein
Thomas Jenuwein
H4K20 methylation is a broad chromatin modification that has been linked with diverse epigenetic functions. Several enzymes target H4K20 methylation, consistent with distinct mono-, di-, and trimethylation states controlling different biological outputs. To analyze the roles of H4K20 methylation states, we generated conditional null alleles for the two Suv4-20h histone methyltransferase (HMTase) genes in the mouse. Suv4-20h-double-null (dn) mice are perinatally lethal and have lost nearly all H4K20me3 and H4K20me2 states. The genome-wide transition to an H4K20me1 state results in increased sensitivity to damaging stress, since Suv4-20h-dn chromatin is less efficient for DNA double-strand break (DSB) repair and prone to chromosomal aberrations. Notably, Suv4-20h-dn B cells are defective in immunoglobulin class-switch recombination, and Suv4-20h-dn deficiency impairs the stem cell pool of lymphoid progenitors. Thus, conversion to an H4K20me1 state results in compromised chromatin that is insufficient to protect genome integrity and to process a DNA-rearranging differentiation program in the mouse.

5 December 2010 in Nature Immunology
Verified
Journal Article
Open access
PDF file
DLDan Levy
Dan Levy
AKAlex J Kuo
Alex J Kuo
YCYanqi Chang
Yanqi Chang
USUwe Schaefer
Uwe Schaefer
CKChristopher Kitson
Christopher Kitson
OGOr Gozani
Or Gozani
Binding of the transcription factor NF-κB subunit RelA activates proinflammatory gene expression. Gozani and colleagues show that basal expression of RelA target genes is suppressed by methylation of RelA by SETD6, which triggers repressive histone methylation by GLP. Signaling via the methylation of lysine residues in proteins has been linked to diverse biological and disease processes, yet the catalytic activity and substrate specificity of many human protein lysine methyltransferases (PKMTs) are unknown. We screened over 40 candidate PKMTs and identified SETD6 as a methyltransferase that monomethylated chromatin-associated transcription factor NF-κB subunit RelA at Lys310 (RelAK310me1). SETD6-mediated methylation rendered RelA inert and attenuated RelA-driven transcriptional programs, including inflammatory responses in primary immune cells. RelAK310me1 was recognized by the ankryin repeat of the histone methyltransferase GLP, which under basal conditions promoted a repressed chromatin state at RelA target genes through GLP-mediated methylation of histone H3 Lys9 (H3K9). NF-κB-activation–linked phosphorylation of RelA at Ser311 by protein kinase C-ζ (PKC-ζ) blocked the binding of GLP to RelAK310me1 and relieved repression of the target gene. Our findings establish a previously uncharacterized mechanism by which chromatin signaling regulates inflammation programs.

1 December 2010 in Molecular Cell
Verified
Journal Article
Closed access
YYYanzhong Yang
Yanzhong Yang
YLYue Lu
Yue Lu
AEAlexsandra Espejo
Alexsandra Espejo
JWJiacai Wu
Jiacai Wu
WXWei Xu
Wei Xu
MBMark Bedford
Mark Bedford

1 February 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AIAimee N. Iberg
Aimee N. Iberg
AEAlexsandra Espejo
Alexsandra Espejo
DCDonghang Cheng
Donghang Cheng
DKDaehoon Kim
Daehoon Kim
JMJonathan Michaud-Levesque
Jonathan Michaud-Levesque
MBMark T. Bedford
Mark T. Bedford
Histone tail post-translational modification results in changes in cellular processes, either by generating or blocking docking sites for histone code readers or by altering the higher order chromatin structure. H3K4me3 is known to mark the promoter regions of active transcription. Proteins bind H3K4 in a methyl-dependent manner and aid in the recruitment of histone-remodeling enzymes and transcriptional cofactors. The H3K4me3 binders harbor methyl-specific chromatin binding domains, including plant homeodomain, Chromo, and tudor domains. Structural analysis of the plant homeodomains present in effector proteins, as well as the WD40 repeats of WDR5, reveals critical contacts between residues in these domains and H3R2. The intimate contact between H3R2 and these domain types leads to the hypothesis that methylation of this arginine residue antagonizes the binding of effector proteins to the N-terminal tail of H3. Here we show that H3 tail binding effector proteins are indeed sensitive to H3R2 methylation and that PRMT6, not CARM1/PRMT4, is the primary methyltransferase acting on this site. We have tested the expression of a select group of H3K4 effector-regulated genes in PRMT6 knockdown cells and found that their levels are altered. Thus, PRMT6 methylates H3R2 and is a negative regulator of N-terminal H3 tail binding.